Together, these findings demonstrate that ARID1A-deficiency leads to CXCL10 and CXCL11 downregulation in organoids, while Li et al showed this downregulation drives immune exclusion in colon cancer. The gene discussed is CXCL10; the disease is colonic neoplasm.